Affordable orphan drugs: a role for not-for-profit organizations.

about

Compounded medication for patients with rare diseases.Drugs for rare disorders.Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

P2860

Q47138573-F4D3E658-F0B9-457E-A367-BF5D5326340C Q47334709-AABE2083-2BD7-4B3B-B88C-F58858166AEB Q49562067-0076C85A-CFAF-4602-9AEE-64E428AE52D4

P2860

Affordable orphan drugs: a role for not-for-profit organizations.

Item

http://www.wikidata.org/entity/Q39008609

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Affordable orphan drugs: a role for not-for-profit organizations.

@en

Affordable orphan drugs: a role for not-for-profit organizations.

@nl

type

Item

label

Affordable orphan drugs: a role for not-for-profit organizations.

@en

Affordable orphan drugs: a role for not-for-profit organizations.

@nl

prefLabel

Affordable orphan drugs: a role for not-for-profit organizations.

@en

Affordable orphan drugs: a role for not-for-profit organizations.

@nl

P1476

Affordable orphan drugs: a role for not-for-profit organizations.

@en

P2093

Daniel Brook

http://www.w3.org/2001/XMLSchema#string

Elin H Davies

http://www.w3.org/2001/XMLSchema#string

Emma Fulton

http://www.w3.org/2001/XMLSchema#string

P2860

The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review

Effectiveness, safety and costs of orphan drugs: an evidence-based review

Profitability and Market Value of Orphan Drug Companies: A Retrospective, Propensity-Matched Case-Control Study

Drug repositioning: identifying and developing new uses for existing drugs

Orphan drug development: an economically viable strategy for biopharma R&D.

Clinical development success rates for investigational drugs.

Drugs for exceptionally rare diseases: do they deserve special status for funding?

Upstream solutions for price-gouging on critical generic medicines.

Access to information supporting availability of medicines for patients suffering from rare diseases looking for possible treatments: the EuOrphan Service.

Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.

P304

1595-1601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13240

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dyfrig A. Hughes

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28109021

http://www.w3.org/2001/XMLSchema#string

P921

orphan drug

P932

5465340

http://www.w3.org/2001/XMLSchema#string

Affordable orphan drugs: a role for not-for-profit organizations.

about

P2860

P2860

Affordable orphan drugs: a role for not-for-profit organizations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932